바이오 그린 메드 솔루션BGMS 주가

[10-Q] 분기 실적 — 10-Q

Cyclacel Pharmaceuticals Q1 EPS $(0.04) Up From $(11.52) YoY, Sales $778.000K

Cyclacel Pharmaceuticals (NASDAQ:BGMS) reported quarterly losses of $(0.04) per share. This is a 99.65 percent increase over losses of $(11.52) per share from the same period last year. The company reported $778.000

BIO GREEN MED SOLUTION REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

KUALA LUMPUR, MALAYSIA, May 14, 2026 -- Bio Green Med Solution, Inc. , a diversified company engaged primarily in the provision of fire safety protection and distribution activities, today...

[8-K] 중대 사건 — 8-K

[SCHEDULE 13G/A] SCHEDULE 13G/A

[DEFR14A] DEFR14A — DEFR14A

[DEF 14A] 주주총회 위임장 — DEF 14A

[8-K] 중대 사건 — 8-K

[10-K] 연 실적 — 10-K

[8-K] 중대 사건 — 8-K